Bayer has agreed to pay more than $10 billion to settle thousands of claims that the popular weedkiller Roundup causes cancer. But a plan for handling future claims from customers who develop
non-Hodgkin’s lymphoma cancer requires court approval. Judge Vince Chhabria of U.S. District Court in San Francisco warned in a filing that he “is skeptical of the propriety and fairness
of the proposed settlement, and is tentatively inclined to deny the motion.”
Read the whole story at The New York Times »